SCOPUS 정보 검색 플랫폼

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 5, 2005, Pages 1095-1096

Has the cost-effectiveness of Xolair (omalizumab) been underestimated? [5] (multiple letters)

(5) Asche, Carl V a Brixner, Diana I a Oderda, Gary M a Oba, Yuji b Salzman, Gary A b

a UNIVERSITY OF UTAH (United States)

b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMALIZUMAB;

ASTHMA; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EMERGENCY WARD; FIRST AID; HOSPITALIZATION; HUMAN; LETTER; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 18144391546 PISSN: 00916749 EISSN: None Source Type: Journal
DOI: 10.1016/j.jaci.2004.12.1136 Document Type: Letter

Times cited : (6)

References (3)

1
- 18144391546
- Has the cost-effectiveness of Xolair (omalizumab) been underestimated?
- C.V. Asche D.I. Brixner G.M. Oderda Has the cost-effectiveness of Xolair (omalizumab) been underestimated? J Allergy Clin Immunol 115 2005 1095
- (2005) J Allergy Clin Immunol , vol.115 , pp. 1095
- Asche, C.V.¹ Brixner, D.I.² Oderda, G.M.³

2
- 0036169394
- Direct and indirect costs of asthma to an employer
- H.G. Birnbaum W.E. Berger P.E. Greenberg M. Holland R. Auerbach K.M. Atkins Direct and indirect costs of asthma to an employer J Allergy Clin Immunol 109 2002 264 270
- (2002) J Allergy Clin Immunol , vol.109 , pp. 264-270
- Birnbaum, H.G.¹ Berger, W.E.² Greenberg, P.E.³ Holland, M.⁴ Auerbach, R.⁵ Atkins, K.M.⁶

3
- 0342902205
- Is the placebo powerless? An analysis of clinical trials comparing placebo treatment with no treatment
- A. Hróbjartsson P.C. Gøtzsche Is the placebo powerless? An analysis of clinical trials comparing placebo treatment with no treatment N Engl J Med 344 2001 1594 1602
- (2001) N Engl J Med , vol.344 , pp. 1594-1602
- Hróbjartsson, A.¹ Gøtzsche, P.C.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.